Associated Medical Schools of New York

Researchers at New York Medical College have made a major breakthrough that could transform how we treat liver disease—moving beyond just managing symptoms to actually stopping and reversing the disease itself! 🔬

Liver disease kills millions annually, yet current treatments only manage complications rather than cure the disease. Conditions like metabolic dysfunction-associated liver disease (MASLD) and cirrhosis have been incredibly difficult to treat effectively.

The research team, led by Dr. Victor Garcia and Dr. Michal Laniado Schwartzman, has uncovered how key pathways and their associated receptors drive liver disease progression.

This research represents hope for the millions affected by liver disease worldwide. From the lab bench to potential life-saving treatments—this is medical research making a real difference! 🌟

Learn more: https://www.nymc.edu/newsroom/stories/gpr75-and-liver-disease-research-study.php.

Study Links Cellular Receptor GPR75 to the Progression of Liver Disease Findings by New York Medical College Researchers Could Offer a New Path to Treating Liver Disease

🧠 For decades, scientists believed that the adult brain couldn’t generate new neurons. New of Rochester research proves otherwise, offering hope for patients with Huntington’s disease.

Dr. Abdellatif Benraiss and his team discovered they can stimulate the brain's own progenitor cells to create new neurons that integrate naturally into motor control networks.

The game-changing findings:
✅ Adult brains contain reservoirs of progenitor cells capable of producing neurons
✅ New neurons migrate to the striatum—the brain region affected by Huntington’s
✅ These cells develop into medium spiny neurons—the type of cells lost from Huntington’s

Read the full article here: https://www.urmc.rochester.edu/news/story/brains-own-repair-mechanism-new-neurons-may-reverse-damage-in-huntingtons-disease

Brain’s Own Repair Mechanism: New Neurons May Reverse Damage in Huntington’s Disease A new study shows that the adult brain can generate new neurons that integrate into key motor circuits, findings that may point to a new way to treat neurogenerative disorders.

Post-MPN AML is a devastating condition where one blood cancer transforms into an even more aggressive form of leukemia. Current treatments typically extend survival by less than a year—until now.

Dr. Marina Konopleva and her team at Albert Einstein College of Medicine identified a protein called BCL-xL that these cancer cells desperately need to survive. Think of it as the cancer's "life support system."

A new experimental medicine can target and destroy this protein without harming healthy platelets. When combined with existing chemotherapy, it successfully blocked cancer cell growth in patient samples.

Research like this reminds us why funding cancer research is so critical—every breakthrough brings us closer to improving patient well-being. Learn more: https://montefioreeinstein.org/news/2025/04/30/possible-new-treatment-form-acute-myeloid-leukemia.

Possible New Treatment for Form of Acute Myeloid Leukemia News Brief Possible New Treatment for Form of Acute Myeloid Leukemia April 30, 2025 Body Post-MPN AMLis is a condition in which a myeloproliferative neoplasm (MPN) develops into acute myeloid leukemia (AML). Patients with post-MPN AML don’t respond to currently available therapies for either AML o...

🎓 Congratulations to the fourth graduating class of NYU Grossman School of Medicine - Long Island! On May 13, the school honored 23 new physicians committed to advancing primary care and addressing critical physician shortages in underserved communities.

The milestone highlights the school’s impact as the nation’s first tuition-free, three-year focused on primary care:

🔑 Keynote speaker Dr. Joseph R. Betancourt from Fund emphasized affordable quality health care

🩺 Amanda Greco became the school’s first student to match to an internal medicine primary care track at NYU Langone’s Tisch Hospital

🏫 Nine graduates matched with York University Langone Health residencies.

Under Dean Dr. Glayds Ayala’s guidance, the new graduates recited the Hippocratic Oath and presented plaques of appreciation to Kenneth and Elaine Langone for their dedication to the school’s mission. These new physicians are ready to make a difference in primary care!

After decades of advocacy, malnutrition-related diabetes is now officially classified as a distinct form of the disease—thanks in part to the groundbreaking research of Dr. Meredith Hawkins at Albert Einstein College of Medicine.

Unlike Type 2 diabetes caused by obesity, Type 5 diabetes stems from malnutrition—too little food, not too much. Dr. Hawkins discovered these patients have a "profound defect in the capacity to secrete insulin," making traditional treatments ineffective and sometimes dangerous.

This milestone represents hope for millions suffering from a form of diabetes the medical world is only beginning to understand. Read more: https://montefioreeinstein.org/news/2025/04/08/einstein-research-leads-designation-new-type-diabetes

Einstein Research Leads to Designation of New Type of Diabetes News Release Einstein Research Leads to Designation of New Type of Diabetes April 8, 2025 (BRONX, NY) Body Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now officially recognized as a distinct form of the diseas...

🏅 Congratulations to six exceptional faculty from Columbia University Irving Medical Center on being elected to prestigious medical honor societies for physician-scientists!

The Association of American Physicians - an honor limited to just 70 physicians annually since 1885 - elected four faculty:
R. Graham Barr (Medicine, VP&S)
Ana Navas-Acien (Environmental Health Sciences, Mailman)
Aimee Payne (Dermatology, VP&S)
Muredach Reilly (Medicine, VP&S)

The American Society for Clinical Investigation has elected two faculty of the Vagelos College of Physicians and Surgeons:
Elizabeth C. Verna (Surgery)
Kelley Yan (Medicine)

Learn more about the honorees: https://mednews.hofstra.edu/2025/04/30/teachers-of-the-year-2024-2025/.

mednews.hofstra.edu

🔬Breaking research could change how we care for diabetic patients’ kidneys.

Dr. Sandeep Mallipattu at Stony Brook University is investigating how kidney cells “talk” to each other—and how this communication could prevent diabetic kidney disease. His groundbreaking approach focuses on two critical cell types: podocytes - the kidney’s filtration barrier and proximal tubule cells - handle metabolism and electrolyte balance.

His hypothesis: Podocytes can actually "signal" proximal tubule cells to protect themselves against injury, potentially slowing diabetic kidney disease progression.

This five-year study runs through February 2029 and represents hope for preventing one of diabetes's most serious complications. Learn more: https://news.stonybrook.edu/newsroom/press-release/medical/investigating-two-major-cell-types-to-help-curb-diabetic-kidney-disease/

Investigating Two Major Cell Types to Help Curb Diabetic Kidney Disease - SBU News Research supported by a $2.76 million NIDDK grant to Dr. Sandeep Mallipattu STONY BROOK, NY, May 1, 2025 – Preserving the health of kidneys in patients with diabetes can be challenging because the disease often brings complications over time. Sandeep Mallipattu, MD, Professor of Medicine and Chief...

🔬 Groundbreaking discovery: New York Medical College College researchers have discovered and characterized a completely novel strain of Treponema pallidum (the bacterium that causes syphilis), officially designated NYMC01! This strain causes painful lesions and challenges the long-held belief that syphilitic chancres are always painless. 🧬

Lead researcher Dr. Maria Rosa Velasquez hopes that clinicians will consider syphilis when diagnosing patients with painful lesions. As she explains, early and accurate recognition of syphilis is critical for timely treatment, preventing transmission, and controlling public health impact.

Learn more about Dr. Velasquez’s discovery: https://www.nymc.edu/newsroom/stories/nymc01-novel-bacterial-strain-found.php.

New York Medical College Researchers Identify Novel Strain of Syphilis Bacterium Designated NYMC01, The New Strain Linked to Painful Oral Lesions Challenges Established Diagnostic Methods

The American Academy of Dermatology recently appointed Alina Bridges, Associate Professor of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra University and Northwell Health ealth, to its board of directors.

Dr. Bridges has advanced diagnostic techniques for complex skin conditions. With her distinguished career in dermatopathology, she is ready to promote dermatologic research and enhance medical education in dermatology. Congratulations, Dr. Bridges!

Learn more: https://mednews.hofstra.edu/2025/04/11/faculty-member-appointed-to-aad-board-of-directors/.

mednews.hofstra.edu

💻 Is in medicine playing fair?

New research from the Icahn School of Medicine at Mount Sinai reveals how AI recommendations change based on socioeconomic status, not medical need. AI models often recommend advanced tests (CT, MRI) for high-income patients, but no further testing for low income patients.

This research helps build vital safeguards to ensure AI benefits all patients equally. Learn more: https://www.mountsinai.org/about/newsroom/2025/is-ai-in-medicine-playing-fair

Is AI in Medicine Playing Fair? | Mount Sinai - New York A new study raises concerns regarding responsible AI in health care. Researchers at the Icahn School of Medicine at Mount Sinai found that AI models can make different treatment recommendations for the same medical condition based on a patient's socioeconomic and demographic background. This highlig...

The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell has just been recognized as Tier 1 in the U.S. News & World Report 2025 Best Medical Schools rankings for research!

The school is one of only 16 medical schools nationwide and just 1 of 2 schools in New York State to achieve this prestigious designation! 🗽

Here’s what sets the school apart:
🔬 Nearly ALL our students engage in research between their first and second year

🤝 Innovative partnership with Northwell Health providing unmatched clinical research opportunities

🏥 Access to the Feinstein Institutes for Medical Research - world-class facilities right at our fingertips

🧬 Collaborations with Cold Spring Harbor Laboratory and other prestigious research partners

Congratulations to the incredible faculty, students, and research partners who make this achievement possible! 🎉 Read more: https://mednews.hofstra.edu/2025/04/08/zucker-school-of-medicine-ranked-among-top-schools-for-research-by-u-s-news-and-world-report/.

Zucker School of Medicine Ranked Among Top Schools for Research by U.S. News and World Report – Donald & Barbara Zucker School of Medicine at Hofstra/Northwell Research • Top Stories • Zucker School of Medicine Zucker School of Medicine Ranked Among Top Schools for Research by U.S. News and World Report April 8, 20252 Min Read Lois Bentivegna Add Comment HEMPSTEAD, NY, April 8, 2025 – The Donald and Barbara Zucker School of Medicine at Hofstra/Northw...

Congratulations to the 2024-2025 Distinguished Teachers of the Year at the Donald and Barbara School of Medicine at Hofstra University and Northwell Health! Students chose two exceptional educators:

🧪 Dr. Joel N.H. Stern - Professor of Science Education, Molecular Medicine, Neurology and Urology, who received this honor for the third time! He leads our Office of Medical Student Research, helping achieve our prestigious Tier 1 research ranking by U.S. News and World Report - one of only 16 medical schools nationwide to receive this distinction.

🧠 Dr. Cary Buckner, Assistant Professor of Neurology and practicing neurohospitalist, who brings decades of clinical excellence and compassionate teaching to future physicians.

Learn more about the honorees: https://mednews.hofstra.edu/2025/04/30/teachers-of-the-year-2024-2025/.

mednews.hofstra.edu